- Home
- OBIO vs ESOA Comparison
OBIO vs ESOA Comparison
Compare OBIO & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OBIO | ESOA |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Water Sewer Pipeline Comm & Power Line Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 146.2M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | OBIO | ESOA |
|---|---|---|
| Price | $4.53 | $8.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $14.00 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 325.3K | 182.2K |
| Earning Date | 11-10-2025 | 12-09-2025 |
| Dividend Yield | N/A | ★ 1.38% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $2,818,000.00 | ★ $411,001,373.00 |
| Revenue This Year | $36.43 | $0.24 |
| Revenue Next Year | $2.56 | $8.00 |
| P/E Ratio | ★ N/A | $434.50 |
| Revenue Growth | 6.46 | ★ 16.80 |
| 52 Week Low | $2.20 | $7.64 |
| 52 Week High | $6.30 | $19.83 |
Technical Indicators
Market Signals| Indicator | OBIO | ESOA |
|---|---|---|
| Relative Strength Index (RSI) | 52.07 | 39.84 |
| Support Level | $4.19 | $8.25 |
| Resistance Level | $4.69 | $8.95 |
| Average True Range (ATR) | 0.31 | 0.45 |
| MACD | -0.08 | 0.05 |
| Stochastic Oscillator | 27.15 | 59.29 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About ESOA Energy Services of America Corporation
Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.